Yu Heng
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
-
- Cancer-related molecular mechanisms research
Papers in
-
- Head and Neck Cancer Studies 17
-
- Thyroid Cancer Diagnosis and Treatment 13
- Journals
- Frontiers in Oncology (3 papers)Frontiers in Endocrinology (3 papers)Human Cell (2 papers)Oral Oncology (2 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- ChinaOmanUnited States
In The Last Decade
Yu Heng
54 papers receiving 647 citations
Peers
Comparison fields: 5 of 80
- Otorhinolaryngology 79
- Cancer Research 147
- Endocrinology, Diabetes and Metabolism 133
- Oncology 200
- Immunology 113
Countries citing papers authored by Yu Heng
This map shows the geographic impact of Yu Heng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Heng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Heng more than expected).
Fields of papers citing papers by Yu Heng
This network shows the impact of papers produced by Yu Heng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Heng. The network helps show where Yu Heng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Heng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 7 | |
| 10 | Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis | 2022 | 18 |
| 11 | 2022 | 14 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 21 | |
| 14 | 2021 | 38 | |
| 15 | Diagnostic Role of Dysregulated Circular RNA hsa_circ_0036722 in Laryngeal Squamous Cell Carcinoma | 2020 | 1 |
| 16 | 2020 | 15 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 9 | |
| 19 | 2019 | 3 | |
| 20 | 2019 | 41 |
About Yu Heng
Yu Heng is a scholar working on Otorhinolaryngology, Endocrinology, Diabetes and Metabolism, Oncology, Immunology and Surgery, having authored 59 papers that have together received 651 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (17 papers), Thyroid Cancer Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), Thyroid and Parathyroid Surgery (9 papers), Head and Neck Surgical Oncology (6 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Head and Neck Anomalies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Otorhinolaryngology (79 citations), Cancer Research (147 citations), Endocrinology, Diabetes and Metabolism (133 citations), Oncology (200 citations) and Immunology (113 citations). Yu Heng has collaborated with scholars based in China, Oman and United States. Frequent co-authors include Lei Tao, Zheyu Yang, Xiaoke Zhu, Liang Zhou, Wei Cai, Zhi Yang, Xingzhou Wang, En Xu, Liming Lu and Xuefeng Xia. Their work appears in journals such as Frontiers in Oncology, Frontiers in Endocrinology, Human Cell, Oral Oncology and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.